483 CSL Behring Apr 2003

483 CSL Behring Apr 2003

Humera Khan FDA$595.00 - Available Now

FDA investigators audited the CSL Behring - Bradley, IL, United States facility and issued inspectional observations (via FDA 483) on 01 Apr 2003.

Product details

  • Category: Human Drugs
  • Inspection end: 01 Apr 2003
  • Location: Bradley, United States
  • FEI: 1410248
Add To Cart